Lonza sees no delays for COVID-19 vaccine project, citing Trump backing

Swiss drugmaker Lonza sees no delays for its project to make Moderna's COVID-19 vaccine candidate and has "strong support" from U.S. President Donald Trump to get the necessary manufacturing equipment, its chairman said.